» Articles » PMID: 26577607

Pleuroparenchymal Fibroelastosis: Role of High-resolution Computed Tomography (HRCT) and CT-guided Transthoracic Core Lung Biopsy

Overview
Publisher Springer
Specialty Radiology
Date 2015 Nov 19
PMID 26577607
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Pleuroparenchymal fibroelastosis (PPFE) is a rare idiopathic interstitial pneumonia (IIP) with variable clinical and radiological features. Diagnosis is based on histology obtained by surgical lung biopsy, which is associated with significant mortality and morbidity. This study aims to briefly review PPFE and discuss the role of CT-guided transthoracic core lung biopsy (TTB) in its diagnosis.

Materials/methods: Four cases of PPFE diagnosed at our institution with TTB are reported and discussed.

Results: Clinical, radiological and histological features are in agreement with the previous literature cases. TTB provided the diagnosis in all cases. Iatrogenic pneumothorax was the main complication in all patients. Placement of a chest tube was needed in three patients. An overlap between PPFE and other interstitial lung diseases (ILD) was documented.

Conclusion: PPFE is an underdiagnosed IIP, so radiologist awareness of it needs to be widespread in patients with fibrosis with apical-caudal distribution. Coexistence of different lung diseases strengthens the idea of a predisposing factor. TTB proved to be a good diagnostic tool and can be considered the first choice for invasive assessment of these patients. PFFE has a variable course with no established therapeutic options; therefore a multidisciplinary team is crucial in the approach to patients with ILD.

Main Messages/teaching Points: • PPFE should be considered in the differential diagnosis of fibrosis with apical-caudal distribution. • CT-guided TTB can be considered the first choice for invasive assessment of PPFE. • Site of biopsy has to be chosen carefully in order not to miss PPFE. • Coexistence of different lung diseases strengthens the idea of a predisposing factor. • A multidisciplinary team is crucial in the approach to patients with ILD.

Citing Articles

Multidisciplinary Approach to the Diagnosis of Idiopathic Interstitial Pneumonias: Focus on the Pathologist's Key Role.

Luca S, Pagliuca F, Perrotta F, Ronchi A, Mariniello D, Natale G Int J Mol Sci. 2024; 25(7).

PMID: 38612431 PMC: 11011777. DOI: 10.3390/ijms25073618.


The world of rare interstitial lung diseases.

Buschulte K, Cottin V, Wijsenbeek M, Kreuter M, Diesler R Eur Respir Rev. 2023; 32(167).

PMID: 36754433 PMC: 9910344. DOI: 10.1183/16000617.0161-2022.


Advanced Warning of Aortic Dissection on Non-Contrast CT: The Combination of Deep Learning and Morphological Characteristics.

Yi Y, Mao L, Wang C, Guo Y, Luo X, Jia D Front Cardiovasc Med. 2022; 8:762958.

PMID: 35071345 PMC: 8767113. DOI: 10.3389/fcvm.2021.762958.


Pleuroparenchymal fibroelastosis: from diagnosis to pulmonary rehabilitation.

Candemir I, Ergun P, Demir N BMJ Case Rep. 2021; 14(6).

PMID: 34130969 PMC: 8208016. DOI: 10.1136/bcr-2020-236754.


HRCT Diagnosis of Pleuroparenchymal fibroelastosis: Report of two cases.

Morshid A, Moshksar A, Das A, Duarte A, Palacio D, Villanueva-Meyer J Radiol Case Rep. 2021; 16(6):1564-1569.

PMID: 33981378 PMC: 8085788. DOI: 10.1016/j.radcr.2021.03.051.


References
1.
Kusagaya H, Nakamura Y, Kono M, Kaida Y, Kuroishi S, Enomoto N . Idiopathic pleuroparenchymal fibroelastosis: consideration of a clinicopathological entity in a series of Japanese patients. BMC Pulm Med. 2012; 12:72. PMC: 3539991. DOI: 10.1186/1471-2466-12-72. View

2.
Macedo P, Coker R, Partridge M . Is there a uniform approach to the management of diffuse parenchymal lung disease (DPLD) in the UK? A national benchmarking exercise. BMC Pulm Med. 2007; 7:3. PMC: 1829398. DOI: 10.1186/1471-2466-7-3. View

3.
Klose K, Biesterfeld S, Bocking A . [Percutaneous CT-controlled cutting-needle biopsy of diffuse interstitial and alveolar lung diseases--the technic and results]. Rofo. 1992; 157(1):26-33. DOI: 10.1055/s-2008-1032960. View

4.
Becker C, Gil J, Padilla M . Idiopathic pleuroparenchymal fibroelastosis: an unrecognized or misdiagnosed entity?. Mod Pathol. 2008; 21(6):784-7. DOI: 10.1038/modpathol.2008.56. View

5.
Redondo M, Melo N, Mota P, Jesus J, Moura C, Guimaraes S . Idiopathic pleuroparenchymal fibroelastosis: a rare but increasingly recognized entity. Rev Port Pneumol (2006). 2015; 21(1):41-4. DOI: 10.1016/j.rppnen.2014.04.008. View